Prostate Cancer Genomics - Cancer PHGKB -

Specific PHGKB|Cancer|PHGKB

Prostate Cancer Genomics

- Cancer PHGKB -

What's New

Last Posted: Nov 21, 2018

---

• NCI-MATCH Update: More Labs, New Arms, and Initial Findings  
  NCI, November 15, 2018
• Re: Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate Cancer.  
  Taneja Samir S et al. The Journal of urology 2018 Sep 200(3) 498-499
• Comparison of the Prognostic Utility of the Cell Cycle Progression Score for Predicting Clinical Outcomes in African American and Non-African American Men with Localized Prostate Cancer.  
  Canter Daniel J et al. European urology 2018 Oct
• Transcriptomic heterogeneity in multifocal prostate cancer.  
  Salami Simpa S et al. JCI insight 2018 Nov 3(21)
• Comparing diagnostic and prognostic performance of two-gene promoter methylation panels in tissue biopsies and urines of prostate cancer patients.  
  Moreira-Barbosa Catarina et al. Clinical epigenetics 2018 Oct 10(1) 132
• Entering an era of radiogenomics in prostate cancer risk stratification.  
  Soodana-Prakash Nachiketh et al. Translational andrology and urology 2018 Sep 7(Suppl 4) S443-S452
• Clinical Features and Therapeutic Outcomes in Men with Advanced Prostate Cancer and DNA Mismatch Repair Gene Mutations.  
  Antonarakis Emmanuel S et al. European urology 2018 Oct
• Next-generation sequencing of prostate cancer: genomic and pathway alterations, potential actionability patterns, and relative rate of use of clinical-grade testing.  
  Ikeda Sadakatsu et al. Cancer biology & therapy 2018 Oct 1-8
• RankProd Combined with Genetic Algorithm Optimized Artificial Neural Network Establishes a Diagnostic and Prognostic Prediction Model that Revealed C1QTNF3 as a Biomarker for Prostate Cancer.  
  Hou Qi et al. EBioMedicine 2018 Jun 32234-244
• Development and Validation of a 28-gene Hypoxia-related Prognostic Signature for Localized Prostate Cancer.  
  Yang Lingjian et al. EBioMedicine 2018 May 31182-189